z-logo
open-access-imgOpen Access
7 th International Immunoglobulin Conference: Mechanisms of Action
Author(s) -
Basta M.,
Branch D. R.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12523
Subject(s) - immunology , antibody , receptor , immune system , complement system , immunoglobulin g , glycosylation , complement receptor , medicine , neonatal fc receptor , immunoglobulin fc fragments , biology , biochemistry
Summary Although intravenous immunoglobulin ( IVI g) is widely used for replacement therapy in immunodeficiencies and to treat autoimmune and inflammatory diseases, its mechanisms of action are not fully understood. Examination of immunoglobulin ( I g) receptors, including the F c‐gamma receptors ( FC γ R s) and the neonatal F c receptor, have revealed genetic variations that are linked to autoimmune diseases and to the efficacy of IVI g treatment. However, the beneficial effect of IVI g encompasses multiple mechanisms of action. One of these is scavenging of activated complement fragments, such as C 3a, C 5a, C 3b and C 4b, by infused I g molecules. This interaction prevents binding of complement fragments to their receptors on target cells, thus attenuating the immune damage. Additionally, anti‐inflammatory effects may be facilitated by I g A via specific receptors and/or complement scavenging. Glycosylation of both the F c‐ and F ab‐fragments has also been implicated in the anti‐inflammatory action of IVI g. Although there is evidence to support a role for sialylated I g G glycovariants in mediating the effect of IVI g, evidence from animal models of inflammatory disease suggest that sialylation may not be a critical factor. However, an increase in I g G glycosylation has been observed following IVI g treatment in G uillain‐ B arré syndrome patients, and this has been associated with improved clinical outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here